Navigation Links
Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Date:9/25/2007

National Speakers and Panelists to Discuss Trends, Trials, and Innovation

in Cardiovascular Medicine at Upcoming Conferences

CLEVELAND, Sept. 25 /PRNewswire/ -- Cleveland Clinic is hosting two upcoming Summits that will focus on medical innovation and emerging trends in cardiovascular medicine.

-- Oct. 1-3: Innovation is driving the development of new therapies,

treatments and devices to treat cardiovascular disease. The 5th annual

Cleveland Clinic Medical Innovation Summit will examine trends in

medical innovation and cardiovascular technologies. The Innovation

Summit is an international gathering of health care, business and media

leaders and other decision-makers to dissect advances revolutionizing

health care and how to accelerate the application of life-saving

medical technologies. Also featured will be the Cleveland Clinic's

annual selection of the "Top 10" health care innovations, live,

interactive surgeries and in-depth debates on industry challenges. For

more information on the Medical Innovation Summit, including the

agenda, please visit

http://www.clevelandclinic.org/innovations/summit/.

-- Oct. 18-20: Cleveland Clinic Kaufman Center for Heart Failure, in

cooperation with the American Association for Thoracic Surgery (AATS)

and the American College of Cardiology Foundation (ACCF), will present

an advanced review of emerging medical and surgical treatments of heart

failure. The Summit, called the 21st Century Treatment of Heart

Failure, will feature presentations by leading names in cardiovascular

medicine and cardiac surgery. Topics will include: new therapies to

reverse remodeling; drugs, genes, and cellular targets; the newest

assist devices, with an upda
'/>"/>

SOURCE Cleveland Clinic
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival Benefits as Mitigator Against Radiation-Induced Damage in Study
2. Cholesterol Drug Fails to Slow Progression of Coronary Disease, Cleveland Clinic Study Reports
3. Genetic Analysis Systems Enter the Clinical Mainstream
4. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
5. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
6. Sygnis Pharma AG announces date for presentation of clinical results
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
9. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
10. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
11. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...RNewswire/ -- Axentis Pharma AG has,initiated a cl...lerability,of a new therapeutic formulation for th...c fibrosis patients. The new formulation allows an...ectly to the site of,infection. The forthcoming tr... doses of the new drug. Initial results are expect...
(Date:9/4/2008)...cation for Targeted Therapies That En...TON BEACH, Calif., and AMSTERDAM, Netherlands, Sep...lecular cancer diagnostics,today announced the la...,allows physicians to quantitatively determine the...ER), progesterone receptor (PR) and Human Epiderma...
(Date:9/3/2008)...g Children Studied. Wrong,Conclusions Reached., N...ters for Disease,Control and Prevention (CDC) stud...he MMR vaccine and autism. The National Autism Ass...pel the growing public concern over a,vaccine-auti...ing design,and methodology., For years, parents h...
(Date:9/3/2008)...chronically infected Hepatitis C,patients strongly... in 2008, - Study is the first to show a statist...effect of therapeutic Hepatitis C vaccination, -...a second generation, vaccine formulated with Inte... activation, VIENNA, Austr...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2CDC Misses Target With Flawed MMR/Autism Study 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4New approach builds better proteins inside a computer 863 1New approach builds better proteins inside a computer 863 2New approach builds better proteins inside a computer 863 3New approach builds better proteins inside a computer 863 4Changing the global dietary environment 861 1Changing the global dietary environment 861 2Deadlines for 2007 National Soybean Rust Symposium fast approaching 859 1Deadlines for 2007 National Soybean Rust Symposium fast approaching 859 2Tolerance to inhalants may be caused by changes in gene expression 857 1Tolerance to inhalants may be caused by changes in gene expression 857 2
...7 - EPIX,Pharmaceuticals, Inc. (NASDAQ: EPIX) toda...X-00023, a novel long-acting 5-HT1A agonist,was f...l New,Clinical Drug Evaluation Unit (NCDEU) Meetin... by the National Institutes of,Health and the Amer...presentation highlighted data from a randomized,d...
... Prolexys,Pharmaceuticals and announced today a pu...ve small molecule anti-tumor agent,erastin. Prole...omics technology to understand the mechanism of ac...he June 14, 2007 issue,of the journal Nature revea...endent anion channels (VDACs) -- a novel target fo...
Other Medicine Technology:EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 2Prolexys Pharmaceuticals and Columbia University Researchers,Publish Study on Anti-Tumor Properties of a Selective Small,Molecule Anti-Tumor Agent With Novel Mechanism of Action 3
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
...ly hurt in a farm accident, claimed a chance for s... The 16 year old teenage boy had suffered grave in... helicopter. Insp Roger McConnell, who accompanied...n't want to take all the credit, because the fire ...
...arize and improve collaboration regarding the emer...se, more specifically bird flu//, a training progr...scenario involving transfer of a suspected case of...er was simulated. The Baptist Hospital and the Qu...
...eat promise for new treatments for many conditions... types of adult tissue//. But the human embryo ste... scientists believe the human testicle may provide...or stem cell research. A German team has describ...
...g sensitive to noise, and do not like it much! Acc...noisy surroundings// may face an increased risk of... revealed that the chances of urban middle-aged ad...and amidst a lot of din, stood a 46 percent chance...
Other Medicine News:Health News:Human Testicular Cells Would Help In Stem Cell Research 2
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
...WideBiter Punch series facilitates fast and effect... smooth, anatomically shaped meniscal rim. The fla...e to access even the tightest joint spaces. Made i...f engineering experience in arthroscopy hand instr...
Medicine Products: